Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Large Is the Pain Management Drugs Market Expected to Be in 2029?
The market for pain management medications has shown consistent growth over recent years, expanding from $80.13 billion in 2024 to $83.69 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.4%. Factors contributing to this growth during the historic period include an increase in chronic pain and cancer incidences, a surge in surgical operations, enhanced pain evaluation techniques, and government-driven initiatives.
The market size of pain management drugs is predicted to witness significant growth in the near future. It is projected to reach “$104.19 billion in 2029, with a compound annual growth rate (CAGR) of 5.6%.” This increase during the forecast period can be credited to non-opioid alternatives, targeted treatments, precision medicine strategies, psychological treatments, and an emphasis on the reduction of side effects. The forecast period will likely see trends such as value-based healthcare, expanded access programs, combined therapy approaches, creative formulations, and biosimilar pain drugs.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9846&type=smp
What Are The Contributors To Demand In The Pain Management Drugs Market?
The escalating number of surgeries is anticipated to boost the expansion of the pain management drugs market. Surgery is a medical procedure that includes cutting or penetrating body tissues to treat illnesses, conditions, injuries, modify bodily functions, or enhance appearance. Pain management drugs are essential during surgeries as they help manage and ease post-operative pain, significantly contributing to patient comfort and recovery. For example, the Global Survey 2022 report released in September 2023 by the International Society of Aesthetic Plastic Surgery, a US-based certification body for aesthetic plastic surgeons, revealed an overall 11.2% increase in the number of procedures carried out by plastic surgeons in 2022, with more than 14.9 million surgeries performed worldwide. The report showed a steady growth in aesthetic surgery over the past four years, with a 41.3% surge. Hence, the rising trend of surgeries is fuelling the growth of the pain management drugs market.
What Segmentation Categories Are Included In The Pain Management Drugs Market Analysis?
The pain management drugs market covered in this report is segmented –
1) By Drug Class: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Anesthetics, Anticonvulsants, Anti-Migraine Agents, Antidepressants, Opioids, Nonnarcotic Analgesics
2) By Indication: Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Back Pain, Postoperative Pain, Migraine, Fibromyalgia, Muscle Sprain Or Strain, Bone Fracture, Other Indications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Aspirin, Diclofenac, Ketorolac
2) By Anesthetics: Local Anesthetics, General Anesthetics
3) By Anticonvulsants: Gabapentin, Pregabalin, Carbamazepine, Topiramate
4) By Anti-Migraine Agents: Triptans, Ergot Alkaloids, CGRP Inhibitors
5) By Antidepressants: Tricyclic Antidepressants, SNRIs
6) By Opioids: Morphine, Oxycodone, Hydrocodone, Fentanyl
7) By Nonnarcotic Analgesics: Acetaminophen, Aspirin, Other Analgesics
How Are Key Trends Driving Expansion In The Pain Management Drugs Industry?
The rise of technology is a notable trend being observed in the pain management drugs market. A majority of companies in this market are centering their efforts on technological innovation. For instance, in October 2024, a significant development was announced by Vertex Pharmaceuticals, an American biotechnology firm. They revealed advancements in a novel medication called Suzetrigine (VX-548), intended for use in treating acute and neuropathic pain. What sets this drug apart is its ability to provide efficient pain relief without the common side effects linked with conventional analgesics. The introduction of Suzetrigine is seen as a move that will broaden the treatment choices for patients afflicted with different pain conditions, thereby enhancing their life quality. With the forward movement of this inventive therapy, Vertex has plans to fulfil the unmet medical requirements in pain management, thereby cementing its position as a frontline player in the pharmaceutical field.
Who Are The Top-Ranked Companies In The Pain Management Drugs Market Today?
Major companies operating in the pain management drugs market include Novartis AG, Eli Lilly And Company, Abbott Laboratories, Endo International plc, Pfizer Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., GlaxoSmithKline plc, AbbVie Inc., Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Bausch Health Companies Inc., Sanofi, F. Hoffmann-La Roche Ltd., Boehringer Ingelheim, Mallinckrodt Pharmaceuticals, Daiichi Sankyo Company Limited, Grünenthal GmbH, Mundipharma International Limited, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Zydus Cadila, Lupin Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd.
Get The Full Report Here:
https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report
How Is Pain Management Drugs Market Adoption Varying Across Different Regions And Sectors?
North America was the largest region in the pain management drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the pain management drug market report during the forecast period. The regions covered in the pain management drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=9846&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model